翻訳と辞書 |
ZIOPHARM Oncology : ウィキペディア英語版 | ZIOPHARM Oncology
ZIOPHARM Oncology is a publicly held, clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, that develops novel immunotherapies for the treatment of cancer. In 2011, ZIOPHARM established a partnership with Intrexon Corporation to develop and commercialize DNA-based cancer drugs based on Intrexon's synthetic biology technology platform.〔(Langreth, Robert. (7 Jan 2011). "A Biotech Billionaire And His Radical DNA Drug That Kills Cancer From Within" Forbes. )〕 ZIOPHARM has two oncology therapeutics in clinical development, IL-12 DNA and CD-19-Sleeping Beauty Cells, and expects to initiate five additional CAR-T cell therapy clinical programs in 2015.〔(ZIOPHARM Oncology, Inc. FORM 10-K For the fiscal year ended December 31, 2014 )〕 == References ==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「ZIOPHARM Oncology」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|